vs
Side-by-side financial comparison of BankUnited, Inc. (BKU) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $288.2M, roughly 1.7× BankUnited, Inc.). On growth, BankUnited, Inc. posted the faster year-over-year revenue change (9.0% vs -1.7%). Over the past eight quarters, BankUnited, Inc.'s revenue compounded faster (9.2% CAGR vs -0.1%).
BankUnited, Inc. is the bank holding company of BankUnited, N.A., a national bank founded in 1984 and headquartered in Miami Lakes, Florida. The company operates in Florida; the regions in and around Atlanta, Georgia; Dallas, Texas; Morristown, New Jersey; Charlotte, North Carolina; and in the New York metropolitan area. BankUnited also offers certain commercial lending and deposit products through national platforms and has total assets of $35.0 billion as of December 31, 2025
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
BKU vs MD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $288.2M | $493.8M |
| Net Profit | — | $33.7M |
| Gross Margin | — | — |
| Operating Margin | 31.2% | 9.9% |
| Net Margin | — | 6.8% |
| Revenue YoY | 9.0% | -1.7% |
| Net Profit YoY | — | 10.5% |
| EPS (diluted) | $0.89 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $288.2M | $493.8M | ||
| Q3 25 | $275.7M | $492.9M | ||
| Q2 25 | $273.9M | $468.8M | ||
| Q1 25 | $255.4M | $458.4M | ||
| Q4 24 | $264.5M | $502.4M | ||
| Q3 24 | $257.0M | $511.2M | ||
| Q2 24 | $250.2M | $504.3M | ||
| Q1 24 | $241.7M | $495.1M |
| Q4 25 | — | $33.7M | ||
| Q3 25 | $71.9M | $71.7M | ||
| Q2 25 | $68.8M | $39.3M | ||
| Q1 25 | $58.5M | $20.7M | ||
| Q4 24 | — | $30.5M | ||
| Q3 24 | $61.5M | $19.4M | ||
| Q2 24 | $53.7M | $-153.0M | ||
| Q1 24 | $48.0M | $4.0M |
| Q4 25 | 31.2% | 9.9% | ||
| Q3 25 | 35.5% | 13.8% | ||
| Q2 25 | 34.3% | 12.8% | ||
| Q1 25 | 31.4% | 7.0% | ||
| Q4 24 | 35.2% | 7.8% | ||
| Q3 24 | 32.4% | 6.6% | ||
| Q2 24 | 29.2% | -31.3% | ||
| Q1 24 | 27.8% | 3.2% |
| Q4 25 | — | 6.8% | ||
| Q3 25 | 26.1% | 14.5% | ||
| Q2 25 | 25.1% | 8.4% | ||
| Q1 25 | 22.9% | 4.5% | ||
| Q4 24 | — | 6.1% | ||
| Q3 24 | 23.9% | 3.8% | ||
| Q2 24 | 21.5% | -30.3% | ||
| Q1 24 | 19.8% | 0.8% |
| Q4 25 | $0.89 | $0.40 | ||
| Q3 25 | $0.95 | $0.84 | ||
| Q2 25 | $0.91 | $0.46 | ||
| Q1 25 | $0.78 | $0.24 | ||
| Q4 24 | $0.91 | $0.37 | ||
| Q3 24 | $0.81 | $0.23 | ||
| Q2 24 | $0.72 | $-1.84 | ||
| Q1 24 | $0.64 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $217.8M | $375.2M |
| Total DebtLower is stronger | $319.7M | $570.5M |
| Stockholders' EquityBook value | $3.1B | $865.9M |
| Total Assets | $35.0B | $2.2B |
| Debt / EquityLower = less leverage | 0.10× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $217.8M | $375.2M | ||
| Q3 25 | $559.5M | $340.1M | ||
| Q2 25 | $801.3M | $224.7M | ||
| Q1 25 | $443.7M | $99.0M | ||
| Q4 24 | $491.1M | $229.9M | ||
| Q3 24 | $889.9M | $103.8M | ||
| Q2 24 | $433.5M | $19.4M | ||
| Q1 24 | $421.2M | $8.0M |
| Q4 25 | $319.7M | $570.5M | ||
| Q3 25 | $320.4M | $577.2M | ||
| Q2 25 | $708.9M | $583.9M | ||
| Q1 25 | $709.1M | $590.5M | ||
| Q4 24 | $708.6M | $597.1M | ||
| Q3 24 | $708.7M | — | ||
| Q2 24 | $708.8M | — | ||
| Q1 24 | $709.0M | — |
| Q4 25 | $3.1B | $865.9M | ||
| Q3 25 | $3.0B | $890.7M | ||
| Q2 25 | $3.0B | $833.8M | ||
| Q1 25 | $2.9B | $789.2M | ||
| Q4 24 | $2.8B | $764.9M | ||
| Q3 24 | $2.8B | $732.5M | ||
| Q2 24 | $2.7B | $706.5M | ||
| Q1 24 | $2.6B | $856.2M |
| Q4 25 | $35.0B | $2.2B | ||
| Q3 25 | $35.1B | $2.2B | ||
| Q2 25 | $35.5B | $2.1B | ||
| Q1 25 | $34.8B | $2.0B | ||
| Q4 24 | $35.2B | $2.2B | ||
| Q3 24 | $35.8B | $2.1B | ||
| Q2 24 | $35.4B | $2.0B | ||
| Q1 24 | $35.1B | $2.2B |
| Q4 25 | 0.10× | 0.66× | ||
| Q3 25 | 0.11× | 0.65× | ||
| Q2 25 | 0.24× | 0.70× | ||
| Q1 25 | 0.24× | 0.75× | ||
| Q4 24 | 0.25× | 0.78× | ||
| Q3 24 | 0.25× | — | ||
| Q2 24 | 0.26× | — | ||
| Q1 24 | 0.27× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $358.6M | $114.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $358.6M | $114.1M | ||
| Q3 25 | $99.7M | $137.3M | ||
| Q2 25 | $117.6M | $137.2M | ||
| Q1 25 | $16.4M | $-117.5M | ||
| Q4 24 | $433.8M | $133.0M | ||
| Q3 24 | $46.1M | $91.8M | ||
| Q2 24 | $135.7M | $107.0M | ||
| Q1 24 | $66.5M | $-125.2M |
| Q4 25 | — | 3.39× | ||
| Q3 25 | 1.39× | 1.91× | ||
| Q2 25 | 1.71× | 3.49× | ||
| Q1 25 | 0.28× | -5.66× | ||
| Q4 24 | — | 4.36× | ||
| Q3 24 | 0.75× | 4.72× | ||
| Q2 24 | 2.53× | — | ||
| Q1 24 | 1.39× | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BKU
Segment breakdown not available.
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
